Skip to main content
Log in

Evaluation of a platinum-doxorubicin complex in experimental tumor systems

  • Preclinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

On the basis of previous observations indicating that the platinum (II)-doxorubicin complex (coordinated via the amino sugar) was active against resistant ascitic leukemias, the preclinical evaluation of this complex was extended to a variety of experimental tumors, including solid doxorubicin-resistant tumors (P388/DX, B16 melanoma with acquired resistance, and MXT mammary carcinoma with natural resistance). In the treatment of sensitive tumors (Gross leukemia and Lewis lung tumor) the complex provided efficacy comparable to that of doxorubicin. Among resistant models, only P388/DX, which is only weakly responsive to cisplatin itself, showed significant sensitivity to the platinum complex. Since all resistant tumors were transplanted in the same site (s.c.) of the same mouse strain, it is likely that the different tumor response reflects different underlying mechanisms of cell resistance rather than alterations in pharmacologic behavior of the anthracycline after covalent binding to platinum. The data reported in this preclinical study support the potential value of this approach to overcome selected manifestations of resistance to anthracyclines. In contrast to the highly toxic doxorubicin/cisplatin combination, doxorubicin complexation with platinum was not associated to an increase in toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pasini A, Zunino F: New cisplatin analogues. On the way to better antitumor agents. Angew Chem Int Ed Engl 26:615–624, 1987

    Google Scholar 

  2. Zunino F, Savi G, Pasini A: Synthesis and antitumor activity of a platinum(II)-doxorubicin complex. Cancer Chemother Pharmacol 18:180–182, 1986

    Google Scholar 

  3. Pasini A, Pratesi G, Savi G, Zunino F: A doxorubicin-Pt(II) complex. Chemistry and antitumor activity. Inorganica Chimica Acta 137:123–124, 1987

    Google Scholar 

  4. Schabel Jr FM, Skipper HE, Trader MW, Laster Jr WR, Griswold Jr DP, Corbett TH: Establishment of crossresistance profiles for new agents. Cancer Treat Rep 67:905, 1983

    Google Scholar 

  5. Supino R, Prosperi E, Formelli F, Mariani M, Parmiani G:Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention. Br J Cancer 54:33, 1986

    Google Scholar 

  6. Formelli F, Cleris L, Carsana R: Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors. Cancer Chemother Pharmacol 21:329–336, 1988

    Google Scholar 

  7. Geran RI, Greenberg NH, MacDonald MM, Schumacher AM, Abbott BJ: Protocols for screening chemical agents and natural products against animal tumors and other biological systems (third edition). Cancer Chemother Rep 3:2, 1972

    Google Scholar 

  8. Malinge JM, Schwartz A, Leng M: Characterization of the ternary complexes formed in the reaction of cis-diamminedichloroplatinum (II), ethidium bromide and nucleic acids. Nucl Acids Res 15:1779–1796, 1987

    Google Scholar 

  9. Bowler BE, Lippard SJ: Modulation of platinum antitumor drug binding to DNA by linked and free bintercalators. Biochemistry 25:3031–3038, 1986

    Google Scholar 

  10. Bowler BE, Ahmed KJ, Sundquist WI, Hollis LS, Whang EE, Lippard SJ: Synthesis, characterization, and DNAbinding propeties of (1,2-diaminoethane)platinum(II) complexes linked to the DNA intercalator acridine orange by trimethylene and hexamethylene chains. J Am Chem Soc 111:1299–1306, 1989

    Google Scholar 

  11. Kitov S, Ben-Shoshan R, Ringel I, Gibson D, Katzhendler J: The effect of cis-platin analogues derived from aminoalkylaminoanthraquinones on DNA cleavage: an electron microscopy study. Eur J Med Chem 23:381–383, 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zunino, F., Pratesi, G., Formelli, F. et al. Evaluation of a platinum-doxorubicin complex in experimental tumor systems. Invest New Drugs 8, 341–345 (1990). https://doi.org/10.1007/BF00198589

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00198589

Key words

Navigation